Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The company transformed a novel diabetes treatment into a weight-loss powerhouse, outperforming many rivals
Genomic profiling of the UFMylation family genes identifies UFSP2 as a potential tumour suppressor in colon cancer
Tesamorelin has the only direct human RCT evidence for visceral fat reduction, albeit in an HIV-lipodystrophy population
Numerous users report crisper concentration and stronger short-term memory after months of treatment
Ultimately, there is a pressing need to understand whether the beneficial indirect effects of GLP-1RA medications on pancreatic diseases, including PDAC (e.g., weight loss), are negated by direct effects on the pancreas
Arterioscler Thromb Vasc Biol (2019) 39(2):1505
US$ 27.18
US$ 27.60
US$ 27.62
US$ 26.77
US$ 27.98
US$ 25.06
US$ 28.20
US$ 24.13
